News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
715,530 Results
Type
Article (42335)
Company Profile (294)
Press Release (672901)
Section
Business (210375)
Career Advice (2091)
Deals (36626)
Drug Delivery (106)
Drug Development (83019)
Employer Resources (175)
FDA (16548)
Job Trends (15395)
News (355909)
Policy (33880)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (6)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2590)
Accelerated approval (2)
Adcomms (21)
Allergies (84)
Alliances (51366)
ALS (85)
Alzheimer's disease (1364)
Antibody-drug conjugate (ADC) (115)
Approvals (16549)
Artificial intelligence (242)
Autoimmune disease (15)
Automation (14)
Bankruptcy (371)
Best Places to Work (11770)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (188)
Bladder cancer (56)
Brain cancer (26)
Breast cancer (248)
Cancer (2004)
Cardiovascular disease (163)
Career advice (1749)
Career pathing (30)
CAR-T (141)
Cell therapy (398)
Cervical cancer (18)
Clinical research (67222)
Collaboration (781)
Compensation (451)
Complete response letters (25)
COVID-19 (2652)
CRISPR (40)
C-suite (209)
Cystic fibrosis (101)
Data (1930)
Decentralized trials (2)
Denatured (26)
Depression (39)
Diabetes (251)
Diagnostics (6414)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (113)
Drug pricing (107)
Drug shortages (28)
Duchenne muscular dystrophy (85)
Earnings (87836)
Editorial (33)
Employer branding (21)
Employer resources (149)
Events (114460)
Executive appointments (642)
FDA (17663)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (693)
Gene editing (101)
Generative AI (20)
Gene therapy (289)
GLP-1 (718)
Government (4499)
Grass and pollen (4)
Guidances (48)
Healthcare (18988)
Huntington's disease (23)
IgA nephropathy (22)
Immunology and inflammation (112)
Indications (27)
Infectious disease (2781)
Inflammatory bowel disease (135)
Inflation Reduction Act (8)
Influenza (46)
Intellectual property (85)
Interviews (322)
IPO (16762)
IRA (47)
Job creations (4055)
Job search strategy (1492)
Kidney cancer (9)
Labor market (34)
Layoffs (471)
Leadership (16)
Legal (8367)
Liver cancer (71)
Lung cancer (291)
Lymphoma (131)
Machine learning (2)
Management (59)
Manufacturing (277)
MASH (62)
Medical device (13401)
Medtech (13406)
Mergers & acquisitions (20325)
Metabolic disorders (650)
Multiple sclerosis (68)
NASH (17)
Neurodegenerative disease (80)
Neuropsychiatric disorders (26)
Neuroscience (1844)
NextGen: Class of 2025 (6637)
Non-profit (4524)
Northern California (2405)
Now hiring (37)
Obesity (353)
Opinion (226)
Ovarian cancer (73)
Pain (85)
Pancreatic cancer (77)
Parkinson's disease (131)
Partnered (20)
Patents (206)
Patient recruitment (94)
Peanut (49)
People (59030)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20844)
Phase II (29577)
Phase III (22174)
Pipeline (983)
Podcasts (74)
Policy (120)
Postmarket research (2654)
Preclinical (8834)
Press Release (68)
Prostate cancer (93)
Psychedelics (31)
Radiopharmaceuticals (249)
Rare diseases (369)
Real estate (6251)
Recruiting (67)
Regulatory (22981)
Reports (46)
Research institute (2365)
Resumes & cover letters (358)
Rett syndrome (3)
RNA editing (3)
RSV (37)
Schizophrenia (70)
Series A (123)
Series B (78)
Service/supplier (12)
Sickle cell disease (52)
Southern California (2077)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (29)
Startups (3721)
State (2)
Stomach cancer (14)
Supply chain (60)
The Weekly (45)
United States (21128)
Vaccines (673)
Venture capitalists (37)
Webinars (12)
Weight loss (241)
Women's health (33)
Worklife (15)
Date
Today (113)
Last 7 days (621)
Last 30 days (2547)
Last 365 days (34101)
2025 (7870)
2024 (35770)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33137)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (780)
Alabama (49)
Alaska (7)
Arizona (230)
Arkansas (14)
Asia (40577)
Australia (6498)
California (5489)
Canada (1868)
China (480)
Colorado (247)
Connecticut (257)
Delaware (127)
Europe (86497)
Florida (812)
Georgia (190)
Idaho (57)
Illinois (502)
India (24)
Indiana (298)
Iowa (9)
Japan (144)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (833)
Massachusetts (4163)
Michigan (211)
Minnesota (368)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1572)
New Mexico (29)
New York (1571)
North Carolina (931)
North Dakota (7)
Northern California (2405)
Ohio (190)
Oklahoma (14)
Oregon (38)
Pennsylvania (1251)
Puerto Rico (9)
Rhode Island (26)
South America (1160)
South Carolina (18)
South Dakota (1)
Southern California (2077)
Tennessee (92)
Texas (823)
Utah (165)
Virginia (135)
Washington D.C. (57)
Washington State (515)
West Virginia (3)
Wisconsin (51)
715,530 Results for "marinus pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
December 30, 2024
·
11 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
Pharm Country
Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus’ Post Grant Review
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to developing and commercializing innovative therapeutics to treat seizure disorders, today affirmed its commitment to defending its patent portfolio amidst an Inter Partes Review (IPR) challenge of U.S. Patent 11,110,100 from Ovid Therapeutics, Inc. filed on March 26, 2024.
March 27, 2024
·
7 min read
Drug Development
Marinus Pharmaceuticals Announces Key Business Updates for Tuberous Sclerosis Complex Program
Marinus Pharmaceuticals, Inc. today announced completion of enrollment in the global Phase 3 TrustTSC trial evaluating oral ganaxolone for the treatment of seizures associated with tuberous sclerosis complex (TSC) in children and adults.
May 17, 2024
·
7 min read
Pharm Country
Marinus Pharmaceuticals to Present at the RBC Capital Markets 2024 Global Healthcare Conference
Marinus Pharmaceuticals, Inc. today announced that Scott Braunstein, M.D., Chairman and Chief Executive Officer, will be participating in a fireside chat at the RBC Capital Markets 2024 Global Healthcare Conference.
May 2, 2024
·
1 min read
Business
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, reported business highlights and financial results for the first quarter ended March 31, 2024.
May 8, 2024
·
14 min read
Pharm Country
Marinus Pharmaceuticals to Present at Upcoming March 2024 Investor Conferences
Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced that management will present at and participate in the following conferences in March.
February 21, 2024
·
1 min read
Business
Marinus Pharmaceuticals to Provide Business Update and Report First Quarter 2024 Financial Results on May 8, 2024
Marinus Pharmaceuticals, Inc. today announced that it plans to release financial results for the first quarter ended March 31, 2024 before market open on May 8, 2024.
May 1, 2024
·
1 min read
Press Releases
Orion and Marinus terminate agreement for ganaxolone in Europe
December 30, 2024
·
1 min read
Pharm Country
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - April 05, 2024
Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced the grant of inducement awards to two new employees.
April 5, 2024
·
3 min read
1 of 71,553
Next
